Form 4: Merck Executive Dean Y. Li Reports Stock Option Grant and Restricted Stock Unit Award

Dean Y. Li, Executive VP & President, MRL at Merck & Co., Inc., reports the acquisition of stock options and restricted stock units.

Summary

• On April 29, 2025, Dean Y. Li, an Executive VP & President, MRL at Merck & Co., Inc., reported transactions related to derivative securities.
• Li acquired 64,481 stock options with an exercise price of $84.71, vesting in three equal installments starting April 29, 2026, and expiring on April 28, 2035.
• Li also acquired 14,166 restricted stock units, each representing a contingent right to receive one share of Merck & Co., Inc. common stock, vesting in three equal installments starting April 29, 2026, and expiring on April 29, 2028.
• Following these transactions, Li directly owns 80,180.794 shares of Merck & Co., Inc. common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects standard executive compensation practices, indicating confidence in the executive's ability to contribute to the company's success. There are no red flags or negative indicators.

Positives

• The acquisition of stock options and restricted stock units aligns the executive's interests with those of the shareholders.
• The vesting schedules for both the stock options and restricted stock units incentivize long-term performance.

Industry Context

Stock options and restricted stock units are common forms of executive compensation in the pharmaceutical industry, used to incentivize performance and align executive interests with shareholder value.

Comparison to Industry Standards

• Executive compensation packages, including stock options and restricted stock units, are common in the pharmaceutical industry.
• Companies like Pfizer, Johnson & Johnson, and AbbVie also utilize similar equity-based compensation to incentivize their executives.
• The vesting schedules and exercise prices are generally aligned with industry norms to promote long-term value creation.

Stakeholder Impact

• The granting of stock options and restricted stock units can positively impact shareholders by aligning executive interests with long-term company performance.
• Employees may view this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

Merck, Stock Options, Restricted Stock Units, Form 4, Executive Compensation, Beneficial Ownership, Insider Trading